Interleukin-23 — Drug Target

3 drugs 3 marketed

All drugs that target Interleukin-23 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Interleukin-23 Antagonist [EPC]

Marketed (3)

Sunpg 1622 · Sun Pharma Global · Interleukin-23 Antagonist [EPC] · Immunology
Tildrakizumab blocks the action of Interleukin-23, a protein that promotes inflammation.
ILUMYA · SUN PHARMA GLOBAL · Interleukin-23 Antagonist [EPC] · Immunology
TILD · Sun Pharmaceutical Industries Limited · Immunology
Tild is a small molecule that works by interacting with a specific target in the body.